These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31318844)

  • 1. Impact of CYP2C19 Phenotypes on Clinical Efficacy of Stiripentol in Japanese Patients With Dravet Syndrome.
    Yamamoto Y; Takahashi Y; Ikeda H; Imai K; Kagawa Y; Inoue Y
    Ther Drug Monit; 2020 Apr; 42(2):302-308. PubMed ID: 31318844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2C19 polymorphism and concomitant antiepileptic drugs on serum clobazam and N-desmethyl clobazam concentrations in patients with epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Miyakawa K; Nishimura S; Kasai R; Ikeda H; Takayama R; Mogami Y; Yamaguchi T; Terada K; Matsuda K; Inoue Y; Kagawa Y
    Ther Drug Monit; 2013 Jun; 35(3):305-12. PubMed ID: 23666564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy.
    Jogamoto T; Yamamoto Y; Fukuda M; Suzuki Y; Imai K; Takahashi Y; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2017 Feb; 130():7-12. PubMed ID: 28081475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome.
    Kouga T; Shimbo H; Iai M; Yamashita S; Ishii A; Ihara Y; Hirose S; Yamakawa K; Osaka H
    Brain Dev; 2015 Feb; 37(2):243-9. PubMed ID: 24819914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy.
    Peigné S; Chhun S; Tod M; Rey E; Rodrigues C; Chiron C; Pons G; Jullien V
    Clin Pharmacokinet; 2018 Jun; 57(6):739-748. PubMed ID: 28819726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.
    Jullien V; Chhun S; Rey E; Dulac O; Tod M; Chiron C; Pons G
    Clin Pharmacokinet; 2015 May; 54(5):527-36. PubMed ID: 25503589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.
    Morrison G; Crockett J; Blakey G; Sommerville K
    Clin Pharmacol Drug Dev; 2019 Nov; 8(8):1009-1031. PubMed ID: 30791225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
    Elliott J; McCoy B; Clifford T; Wells GA; Coyle D
    Pharmacoeconomics; 2018 Oct; 36(10):1253-1261. PubMed ID: 29761351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
    Buck ML; Goodkin HP
    Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
    Johannessen Landmark C; Heger K; Lund C; Burns ML; Bjørnvold M; Sætre E; Johannessen SI
    Ther Drug Monit; 2020 Oct; 42(5):744-753. PubMed ID: 32558674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.
    Chiron C; Marchand MC; Tran A; Rey E; d'Athis P; Vincent J; Dulac O; Pons G
    Lancet; 2000 Nov; 356(9242):1638-42. PubMed ID: 11089822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiripentol open study in Japanese patients with Dravet syndrome.
    Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
    Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.
    Giraud C; Treluyer JM; Rey E; Chiron C; Vincent J; Pons G; Tran A
    Drug Metab Dispos; 2006 Apr; 34(4):608-11. PubMed ID: 16415114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Drug Interactions on Clobazam and N-Desmethylclobazam Concentrations in Pediatric Patients With Epilepsy.
    Russell GR; Phelps SJ; Shelton CM; Wheless JW
    Ther Drug Monit; 2018 Aug; 40(4):452-462. PubMed ID: 29746397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.